Acetylcholinesterase is located primarily in which compartment of the neuromuscular junction?

Explanation

## Localization of Acetylcholinesterase at the NMJ **Key Point:** Acetylcholinesterase (AChE) is anchored in the **synaptic cleft and basal lamina** of the neuromuscular junction. This strategic positioning allows rapid hydrolysis of acetylcholine immediately after synaptic transmission. ### Structural Organization of the NMJ ```mermaid flowchart TD A[Motor Neuron Terminal]:::action --> B[Synaptic Vesicles containing ACh]:::outcome B --> C[Synaptic Cleft]:::outcome C --> D[AChE in basal lamina]:::action D --> E[Acetate + Choline]:::outcome C --> F[Nicotinic Receptors on Motor End Plate]:::action F --> G[Depolarization & Muscle Contraction]:::outcome ``` ### Function of AChE in the Synaptic Cleft 1. **Rapid termination of signal:** AChE hydrolyzes ACh within 1–2 milliseconds 2. **Prevention of desensitization:** Continuous ACh exposure would cause receptor desensitization; AChE prevents this 3. **Recycling:** Choline is recaptured by the presynaptic terminal via the choline transporter (CHT) for resynthesis of ACh 4. **Precision of neuromuscular transmission:** Ensures one action potential triggers exactly one muscle contraction **High-Yield:** The basal lamina at the NMJ contains a specialized form of AChE called the "asymmetric form" (A₁₂), which is anchored via collagen-like tail (ColQ). This differs from soluble AChE found in plasma. **Mnemonic:** **SPACE** — Synaptic cleft Positioned Acetylcholinesterase Cleaves Esters (ACh) ### Clinical Correlation **Clinical Pearl:** Anticholinesterase drugs (neostigmine, pyridostigmine, edrophonium) inhibit AChE, prolonging ACh action in the synaptic cleft. This is the basis of treatment in myasthenia gravis, where antibodies destroy nicotinic receptors. By increasing ACh duration, the remaining receptors are more likely to be activated.